Recommendations for fertility preservation in patients with lymphomas.

Journal of Assisted Reproduction and Genetics
Kirsten Tryde SchmidtISFP Practice Committee

Abstract

This guideline aims to serve as a reference for fertility specialists and other specialists working with young patients at risk of premature ovarian insufficiency (POI) or testicular dysfunction (TD) due to treatment of Hodgkin or Non-Hodgkin lymphoma. PubMed search of articles addressing risk of POI and TD according to different treatment protocols used in lymphoma patients. PubMed search of articles presenting different options for fertility treatment in cancer patients. The risk of POI/TD depends on the protocol used with the highest risk in patients treated with haematopoietic stem cell transplantation/bone marrow transplantation (HSCT/BMT) and the lowest risk in patients treated with ABVD (Adriamycin, Bleomycin, Vincristine and Decarbazine). The different options of fertility preservation are discussed and their relevance according to treatment protocol, age of the patient and urgency to start treatment. Fertility issues should be discussed with all women of fertile age. Fertility preservation should be offered to young women when relevant. Children should be informed together with their parents. All men should be offered semen cryopreservation regardless of protocol used. At present, there are no established methods of fe...Continue Reading

References

Nov 1, 1989·Clinical Oncology : a Journal of the Royal College of Radiologists·W H WallaceH R Gattamaneni
May 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J E SandersE D Thomas
Jan 1, 1984·Archives of Toxicology. Supplement. = Archiv Für Toxikologie. Supplement·G BonadonnaG Ragni
Jul 1, 1996·Human Reproduction·H NewtonR Gosden
Mar 7, 1998·Bone Marrow Transplantation·E ThibaudR Brauner
Apr 5, 2001·Fertility and Sterility·Y HovavM Almagor
Jun 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gianni BonadonnaPinuccia Valagussa
Apr 7, 2005·The Lancet Oncology·W Hamish B WallaceD Stewart Irvine
Oct 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karolin BehringerUNKNOWN German Hodgkin's Lymphoma Study Group
May 3, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie J LeeUNKNOWN American Society of Clinical Oncology
Jul 20, 2006·Human Reproduction Update·Jacques DonnezMarie-Madeleine Dolmans
Feb 13, 2007·Best Practice & Research. Clinical Obstetrics & Gynaecology·Anne-Maria Suikkari, Viveca Söderström-Anttila
Mar 7, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michael von WolffClaus Yding Andersen
Feb 6, 2010·Reproductive Biomedicine Online·Ana CoboJosé Remohí
Feb 2, 2010·Reproductive Biomedicine Online·Christine DecanterDidier Dewailly
Mar 6, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Gert R Dohle
Jun 24, 2010·Human Reproduction·J de MouzonUNKNOWN European IVF-monitoring (EIM) Consortium, for the European Society of Human Reproduction and Embryology (ESHRE)
Aug 31, 2010·Fertility and Sterility·Sophie E BittingerCatharyn J Stern
Jan 6, 2011·Seminars in Reproductive Medicine·Johan E J SmitzRobert B Gilchrist
Jan 14, 2011·Annals of Medicine·Jacques DonnezMarie-Madeleine Dolmans
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernd GerberUNKNOWN German Breast Group Investigators
Nov 25, 2011·Reproductive Biology and Endocrinology : RB&E·Giovanna FasanoIsabelle Demeestere
Jan 25, 2012·Psycho-oncology·Andrea L Canada, Leslie R Schover

❮ Previous
Next ❯

Citations

Oct 8, 2013·Gynécologie, obstétrique & fertilité·C Decanter, G Robin
Jul 23, 2013·Orphanet Journal of Rare Diseases·Britt van ErvenM Estela Rubio-Gozalbo
Jan 15, 2014·Bone Marrow Transplantation·S JoshiN S Majhail
Nov 5, 2013·La Presse médicale·Catherine PoirotMarie Prades
Nov 22, 2015·Cancer Metastasis Reviews·Mahmoud Salama, Teresa K Woodruff
Mar 30, 2016·Journal de gynécologie, obstétrique et biologie de la reproduction·J BénardM Grynberg
May 18, 2016·Critical Reviews in Oncology/hematology·Mahmoud SalamaPeter Mallmann
Sep 7, 2016·Cancer Epidemiology·Tamara DieschUNKNOWN Swiss Pediatric Oncology Group SPOG
May 30, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alison W LorenUNKNOWN American Society of Clinical Oncology
May 26, 2017·Journal of Oncology Practice·Michele R HanselinThomas B Leininger
May 26, 2017·Expert Review of Anticancer Therapy·Mahmoud Salama, Teresa K Woodruff
Jul 16, 2014·Journal of Assisted Reproduction and Genetics·Héloïse GronierChristine Decanter
Feb 7, 2019·Acta Obstetricia Et Gynecologica Scandinavica·Shanna Logan, Antoinette Anazodo
Sep 3, 2013·Expert Review of Hematology·André Tichelli, Alicia Rovó
Aug 17, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SalamaT K Woodruff
Jul 1, 2019·Heart Failure Reviews·Christian Cadeddu DessalviGiuseppe Mercuro
Aug 23, 2017·Expert Review of Hematology·Mahmoud SalamaPeter Mallmann
Jan 4, 2018·Human Fertility : Journal of the British Fertility Society·Ephia YasminUNKNOWN British Fertility Society
Apr 26, 2014·Reproductive Medicine and Biology·Koji Chiba, Masato Fujisawa
Feb 29, 2020·Fertility and Sterility·Alexander Volodarsky-PerelWilliam Buckett
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SalamaT K Woodruff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.